APA-referens (7:e uppl.)

Smith, C., Touzart, A., Simonin, M., Tran-Quang, C., Hypolite, G., Latiri, M., . . . Asnafi, V. (2023). Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL. Molecular Cancer, 22(1), . https://doi.org/10.1186/s12943-022-01701-x

Chicago-referens (17:e uppl.)

Smith, Charlotte, et al. "Harnessing the MYB-dependent TAL1 5’super-enhancer for Targeted Therapy in T-ALL." Molecular Cancer 22, no. 1 (2023). https://doi.org/10.1186/s12943-022-01701-x.

MLA-referens (9:e uppl.)

Smith, Charlotte, et al. "Harnessing the MYB-dependent TAL1 5’super-enhancer for Targeted Therapy in T-ALL." Molecular Cancer, vol. 22, no. 1, 2023, https://doi.org/10.1186/s12943-022-01701-x.